Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 183

1.

Adolescent exposure to Δ9-tetrahydrocannabinol alters the transcriptional trajectory and dendritic architecture of prefrontal pyramidal neurons.

Miller ML, Chadwick B, Dickstein DL, Purushothaman I, Egervari G, Rahman T, Tessereau C, Hof PR, Roussos P, Shen L, Baxter MG, Hurd YL.

Mol Psychiatry. 2018 Oct 3. doi: 10.1038/s41380-018-0243-x. [Epub ahead of print]

PMID:
30283037
2.

A unique role for DNA (hydroxy)methylation in epigenetic regulation of human inhibitory neurons.

Kozlenkov A, Li J, Apontes P, Hurd YL, Byne WM, Koonin EV, Wegner M, Mukamel EA, Dracheva S.

Sci Adv. 2018 Sep 26;4(9):eaau6190. doi: 10.1126/sciadv.aau6190. eCollection 2018 Sep.

3.

Molecular Genetics and New Medication Strategies for Opioid Addiction.

Hurd YL, O'Brien CP.

Am J Psychiatry. 2018 Oct 1;175(10):935-942. doi: 10.1176/appi.ajp.2018.18030352. Epub 2018 Aug 2.

PMID:
30068261
4.

Striatal Rgs4 regulates feeding and susceptibility to diet-induced obesity.

Michaelides M, Miller ML, Egervari G, Primeaux SD, Gomez JL, Ellis RJ, Landry JA, Szutorisz H, Hoffman AF, Lupica CR, Loos RJF, Thanos PK, Bray GA, Neumaier JF, Zachariou V, Wang GJ, Volkow ND, Hurd YL.

Mol Psychiatry. 2018 Jun 28. doi: 10.1038/s41380-018-0120-7. [Epub ahead of print]

5.

Molecular windows into the human brain for psychiatric disorders.

Egervari G, Kozlenkov A, Dracheva S, Hurd YL.

Mol Psychiatry. 2018 Jun 28. doi: 10.1038/s41380-018-0125-2. [Epub ahead of print] Review.

6.

An atlas of chromatin accessibility in the adult human brain.

Fullard JF, Hauberg ME, Bendl J, Egervari G, Cirnaru MD, Reach SM, Motl J, Ehrlich ME, Hurd YL, Roussos P.

Genome Res. 2018 Aug;28(8):1243-1252. doi: 10.1101/gr.232488.117. Epub 2018 Jun 26.

7.

Brain Cell Type Specific Gene Expression and Co-expression Network Architectures.

McKenzie AT, Wang M, Hauberg ME, Fullard JF, Kozlenkov A, Keenan A, Hurd YL, Dracheva S, Casaccia P, Roussos P, Zhang B.

Sci Rep. 2018 Jun 11;8(1):8868. doi: 10.1038/s41598-018-27293-5.

8.

THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders.

Guennewig B, Bitar M, Obiorah I, Hanks J, O'Brien EA, Kaczorowski DC, Hurd YL, Roussos P, Brennand KJ, Barry G.

Transl Psychiatry. 2018 Apr 25;8(1):89. doi: 10.1038/s41398-018-0137-3.

9.

Can a Framework Be Established for the Safe Use of Ketamine?

Freedman R, Brown AS, Cannon TD, Druss BG, Earls FJ, Escobar J, Hurd YL, Lewis DA, López-Jaramillo C, Luby J, Mayberg HS, Moffitt TE, Oquendo M, Perlis RH, Pine DS, Rush AJ, Tamminga CA, Tohen M, Vieta E, Wisner KL, Xin Y.

Am J Psychiatry. 2018 Jul 1;175(7):587-589. doi: 10.1176/appi.ajp.2018.18030290. Epub 2018 Apr 16. No abstract available.

PMID:
29656666
10.

Cannabidiol, an Adjunct Player in the Antipsychosis Arsenal.

Bassir Nia A, Hurd YL.

Am J Psychiatry. 2018 Mar 1;175(3):197-198. doi: 10.1176/appi.ajp.2017.17121295. No abstract available.

PMID:
29490489
11.

Granulocyte-colony stimulating factor controls neural and behavioral plasticity in response to cocaine.

Calipari ES, Godino A, Peck EG, Salery M, Mervosh NL, Landry JA, Russo SJ, Hurd YL, Nestler EJ, Kiraly DD.

Nat Commun. 2018 Jan 16;9(1):9. doi: 10.1038/s41467-017-01881-x.

12.

Perioperative Patient Beliefs Regarding Potential Effectiveness of Marijuana (Cannabinoids) for Treatment of Pain: A Prospective Population Survey.

Khelemsky Y, Goldberg AT, Hurd YL, Winkel G, Ninh A, Qian L, Oprescu A, Ciccone J, Katz DJ.

Reg Anesth Pain Med. 2017 Sep/Oct;42(5):652-659. doi: 10.1097/AAP.0000000000000654.

PMID:
28796754
13.

A new dawn in cannabinoid neurobiology: The road from molecules to therapeutic discoveries.

Cheer JF, Hurd YL.

Neuropharmacology. 2017 Sep 15;124:1-2. doi: 10.1016/j.neuropharm.2017.07.004. Epub 2017 Jul 8. No abstract available.

PMID:
28694099
14.

Dopamine D2 Receptor Signaling in the Nucleus Accumbens Comprises a Metabolic-Cognitive Brain Interface Regulating Metabolic Components of Glucose Reinforcement.

Michaelides M, Miller ML, DiNieri JA, Gomez JL, Schwartz E, Egervari G, Wang GJ, Mobbs CV, Volkow ND, Hurd YL.

Neuropsychopharmacology. 2017 Nov;42(12):2365-2376. doi: 10.1038/npp.2017.112. Epub 2017 Jun 5.

15.

Cocaine-Induced Chromatin Modifications Associate With Increased Expression and Three-Dimensional Looping of Auts2.

Engmann O, Labonté B, Mitchell A, Bashtrykov P, Calipari ES, Rosenbluh C, Loh YE, Walker DM, Burek D, Hamilton PJ, Issler O, Neve RL, Turecki G, Hurd Y, Chess A, Shen L, Mansuy I, Jeltsch A, Akbarian S, Nestler EJ.

Biol Psychiatry. 2017 Dec 1;82(11):794-805. doi: 10.1016/j.biopsych.2017.04.013. Epub 2017 May 5.

16.

Shaping vulnerability to addiction - the contribution of behavior, neural circuits and molecular mechanisms.

Egervari G, Ciccocioppo R, Jentsch JD, Hurd YL.

Neurosci Biobehav Rev. 2018 Feb;85:117-125. doi: 10.1016/j.neubiorev.2017.05.019. Epub 2017 May 29. Review.

17.

The endocannabinoid system as a target for addiction treatment: Trials and tribulations.

Sloan ME, Gowin JL, Ramchandani VA, Hurd YL, Le Foll B.

Neuropharmacology. 2017 Sep 15;124:73-83. doi: 10.1016/j.neuropharm.2017.05.031. Epub 2017 May 28. Review.

PMID:
28564576
18.

DNA Methylation Profiling of Human Prefrontal Cortex Neurons in Heroin Users Shows Significant Difference between Genomic Contexts of Hyper- and Hypomethylation and a Younger Epigenetic Age.

Kozlenkov A, Jaffe AE, Timashpolsky A, Apontes P, Rudchenko S, Barbu M, Byne W, Hurd YL, Horvath S, Dracheva S.

Genes (Basel). 2017 May 30;8(6). pii: E152. doi: 10.3390/genes8060152.

19.

High times for cannabis: Epigenetic imprint and its legacy on brain and behavior.

Szutorisz H, Hurd YL.

Neurosci Biobehav Rev. 2018 Feb;85:93-101. doi: 10.1016/j.neubiorev.2017.05.011. Epub 2017 May 12. Review.

20.

Ventral striatal regulation of CREM mediates impulsive action and drug addiction vulnerability.

Miller ML, Ren Y, Szutorisz H, Warren NA, Tessereau C, Egervari G, Mlodnicka A, Kapoor M, Chaarani B, Morris CV, Schumann G, Garavan H, Goate AM, Bannon MJ; IMAGEN Consortium, Halperin JM, Hurd YL.

Mol Psychiatry. 2018 May;23(5):1328-1335. doi: 10.1038/mp.2017.80. Epub 2017 Apr 25.

Supplemental Content

Loading ...
Support Center